Amber Lynn Jones, in Duncan, OK - Licensed Practical Nurse

Amber Lynn Jones, is a Licensed Practical Nurse based in Duncan, Oklahoma. Amber Lynn Jones is licensed to practice in Oklahoma (license number 0059848) and her current practice location is 1806 N 5th St, Duncan, Oklahoma. She can be reached at her office (for appointments etc.) via phone at (580) 467-0063.

NPI number for Amber Lynn Jones is 1578086914 and her current mailing address is 1806 N 5th St, Duncan, Oklahoma. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1578086914.

Contact Information

	Amber Lynn Jones,
	1806 N 5th St, Duncan, OK 73533-3641
	(580) 467-0063
	Not Available

Provider's Profile

Full Name	Amber Lynn Jones
Gender	Female
Speciality	Licensed Practical Nurse
Location	1806 N 5th St, Duncan, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1578086914
Provider Enumeration Date: 07/18/2017
Last Update Date: 07/21/2022

Medical Identifiers

Medical identifiers for Amber Lynn Jones such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578086914	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	0059848 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Amber Lynn Jones is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Amber Lynn Jones, 1806 N 5th St, Duncan, OK 73533-3641 Ph: (580) 467-0063	Amber Lynn Jones, 1806 N 5th St, Duncan, OK 73533-3641 Ph: (580) 467-0063

News Archive

Children with headaches have problems sleeping

According to researchers at the Mayo Clinic children who have frequent headaches often also have sleep problems.

New $2.8 million NIH grant to help researchers find better treatments for hemorrhagic strokes

Developing better treatments and an improved understanding of the biology behind brain injury from hemorrhagic strokes is the main goal of a three-year $2.8 million grant to the Translational Genomics Research Institute, Phoenix Children's Hospital, and Barrow Neurological Institute.

PCI after lung cancer treatment reduces risk of brain metastases in stage III NSCLC patients

Stage III non-small cell lung cancer (NSCLC) patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial irradiation (PCI); however, this study did not show an improvement in overall survival with PCI, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

FDA's Oncologic Drugs Advisory Committee votes in favor of FOLOTYN NDA

Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 10-4 that the response rate and duration of response observed with FOLOTYNTM (pralatrexate) are reasonably likely to predict clinical benefit in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

Amber Lynn Jones, - Licensed Practical Nurse in Duncan, OK